Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 7/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 2/20 | 0.43 |
| ▸ | BCR | P11274 | 2/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.42 |
| ▸ | KIT | P10721 | 1/20 | 0.42 |
| ▸ | FLT3 | P36888 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27949369 | 0.97 | CYP1A2 (0.48) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| SCHEMBL29364786 | 0.76 | CYP1A2 (0.77) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| SCHEMBL69484 | 0.76 | CYP1A2 (0.77) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| SCHEMBL627219 | 0.76 | CYP1A2 (0.77) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| SCHEMBL29711 | 0.74 | CYP1A2 (0.72) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| SCHEMBL27845395 | 0.74 | CYP1A2 (0.72) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| SCHEMBL17311956 | 0.74 | CYP1A2 (0.72) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| SCHEMBL29358095 | 0.74 | CYP1A2 (0.72) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| Hydroquinone SCHEMBL6689552 | 0.74 | ESR2 (0.74) | CYP1A2ESR1ESR2ALOX15CYP3A4 | |
| SCHEMBL10719214 | 0.71 | CYP1A2 (0.68) | CYP1A2ESR1ESR2ALOX15CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11597733-B2 | Compounds and compositions for the treatment of parasitic diseases | NOVARTIS AG (CH) | 2023-03-07 | — | — | US | disclosed |
| CN-114920911-A | Method for producing polyisothianaphthene-based conductive polymer | 昭和电工株式会社 | 2022-08-19 | — | — | CN | disclosed |
| CN-110121516-B | Method for producing polyisothianaphthene-based conductive polymer | 昭和电工株式会社 | 2022-07-01 | — | — | CN | disclosed |
| US-11183340-B2 | Method for manufacturing solid electrolytic capacitor | SHOWA DENKO K.K. (JP) | 2021-11-23 | — | — | US | disclosed |
| US-11136432-B2 | Method for producing polyisothianaphthene-based electroconductive polymer | SHOWA DENKO K.K. (JP) | 2021-10-05 | — | — | US | disclosed |
| CN-110121757-B | Method for manufacturing solid electrolytic capacitor | 昭和电工株式会社 | 2021-09-14 | — | — | CN | disclosed |
| US-20200090874-A1 | METHOD FOR MANUFACTURING SOLID ELECTROLYTIC CAPACITOR | SHOWA DENKO K.K. (JP) | 2020-03-19 | — | — | US | disclosed |
| US-20190345287-A1 | METHOD FOR PRODUCING POLYISOTHIANAPHTHENE-BASED ELECTROCONDUCTIVE POLYMER | SHOWA DENKO K.K. (JP) | 2019-11-14 | — | — | US | disclosed |
| EP-3564976-A1 | METHOD FOR MANUFACTURING SOLID ELECTROLYTIC CAPACITOR | Showa Denko K.K. (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-3564290-A1 | METHOD FOR PRODUCING POLYISOTHIANAPHTHENE ELECTROCONDUCTIVE POLYMER | Showa Denko K.K. (JP) | 2019-11-06 | — | — | EP | disclosed |
| CN-101360756-A | Methods and compositions for treating gastrointestinal disorders | IRONWOOD PHARMACEUTICALS INC (US) | 2009-02-04 | — | — | CN | disclosed |
| CN-1863513-A | Abuse-proffed dosage form | GRUENENTHAL GMBH (DE) | 2006-11-15 | — | — | CN | disclosed |
| CN-1863514-A | Abuse-proffed dosage form | GRUENENTHAL GMBH (DE) | 2006-11-15 | — | — | CN | disclosed |
| EP-1711465-A1 | HYDROISOINDOLINE TACHYKININ RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 2006-10-18 | — | — | EP | disclosed |
| EP-1606233-B1 | Phospholipid esters of Clofarabin | HEIDELBERG PHARMA GMBH (DE) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005073191-A1 | HYDROISOINDOLINE TACHYKININ RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2005-08-11 | — | — | WO | disclosed |
| WO-2002062763-A2 | INHIBITION OF RAF KINASE USING QUINOLYL ISOQUINOLYL OR PYRIDYL UREAS | BAYER CORPORATION (US) | 2002-08-15 | — | — | WO | disclosed |
| CN-1049891-C | MDR reversal agents | AMERICAN CYANAMID CO (US) | 2000-03-01 | — | — | CN | disclosed |
| CN-1179418-A | Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists | HOECHST AG (DE) | 1998-04-22 | — | — | CN | disclosed |
| CN-1114650-A | MDR reversal agents | AMERICAN CYANAMID CO (US) | 1996-01-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11597733-B2 | Compounds and compositions for the treatment of parasitic diseases | ABCB11, SQLE, FURIN | CYP1A2 117/4885ESR1 4722/4885ESR2 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.